Md. biopharm gets $1M NIH grant to study drug

Neuralstem Inc., a biopharmaceutical company, recently received a grant worth up to nearly $1 million from the National Institutes of Health. The Germantown company received the research grant, to evaluate over two years the ability of its small molecule compound, NSI-189 to prevent and treat diabetic neuropathy. In a previous study, NSI-189 was shown to significantly protect motor and sensory …

from http://thedailyrecord.com/2017/08/02/template-business-story-no-byline-special-to-tdr-etc/

Advertisements

Author: Baltimore Checkbook

Best in consumer news and deals in Baltimore, MD.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s